RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
高 P-TLS 密度和低 TSP(L-TSP)是 nmCRC 患者的独立且有利的预后因素,这可能为 CRC 肿瘤微环境,特别是肿瘤免疫微环境中的靶向治疗提供新方向。
三级淋巴结构(TLSs)在促进和维持正向抗肿瘤免疫应答中至关重要。肿瘤间质具有强大的免疫抑制功能,可将TIL(肿瘤浸润淋巴细胞)排除在肿瘤床之外,并导致“冷”表型。TLSs和肿瘤间质百分比(TSP)与某些癌症患者的预后显著相关。然而,在结直肠癌(CRC)中,TLSs和TSP的确切作用及其内在关系仍很大程度上未知。
在训练集的114例CRC患者和外部验证集的60例CRC患者中,通过苏木精-伊红(H&E)和/或免疫组化(IHC)染色评估TLSs和TSP。评估TILs、TLS与临床病理特征之间的相关性及其预后价值。最后,我们绘制了一个包含TLS、TSP和肿瘤-淋巴结-转移(TNM)分期的Nomogram,用于预测非转移性结直肠癌(nmCRC)患者2年和5年无复发生存(RFS)的概率。
瘤周TLS(P-TLS)、瘤内TLS(In-TLS)和高TSP(H-TSP,>50%)分别存在于99.1%、26.3%和41.2%的患者中。H-TSP肿瘤倾向于与较低的P-TLS密度相关(P=0.0205)。低P-TLS密度(< 0.098/mm²)与nmCRC患者无复发生存期(RFS)缩短(HR=6.597 95% CI:2.882-15.103,P < 0.001)和总生存期(OS)缩短(HR=6.628 95% CI:2.893-15.183,P < 0.001)显著相关。In-TLS在评估nmCRC患者临床结局方面无显著意义。H-TSP与nmCRC患者RFS缩短(HR=0.126 95% CI:0.048-0.333,P < 0.001)和OS缩短(HR=0.125 95% CI:0.047-0.332,P < 0.001)显著相关。高P-TLS组、低TLS组、H-TSP组和L-TSP组的5年RFS分别为89.7%、47.2%、53.2%和92.5%。P-TLS密度、TSP和TNM分期是nmCRC患者的独立预后因素。包含P-TLS密度、TSP和TNM分期的列线图优于TNM分期。
Tertiary lymphoid structures (TLSs) are crucial in promoting and maintaining positive anti-tumor immune responses. The tumor stroma has a powerful immunosuppressive function that could exclude tumor-infiltrating lymphocytes from the tumor beds and lead to a "cold" phenotype. TLSs and tumor stroma percentage (TSP) are significantly associated with the prognosis of patients with certain cancers. However, the exact roles of TLSs and TSP and their intrinsic relationship are still largely unknown in colorectal cancer (CRC).
TLSs and TSP were assessed using hematoxylin-eosin (H&E) and/or immunohistochemistry (IHC) staining from 114 CRC patients in the training set and 60 CRC patients in the external validation set. The correlation between TILs, TLS and clinicopathological characteristics and their prognostic values were assessed. Finally, we plotted a Nomogram including the TLS, TSP and tumor-node-metastasis (TNM) stage to predict the probability of recurrence-free survival (RFS) at 2- and 5-years in non-metastatic colorectal cancer (nmCRC) patients.
Peritumoral TLS (P-TLS), intratumoral TLS (In-TLS) and high TSP (H-TSP, >50%) were present in 99.1%, 26.3% and 41.2% patients, respectively. H-TSP tumor tends to be associated with lower P-TLS density ( P =0.0205). The low P-TLS density (< 0.098/mm 2 ) was significantly associated with reduced RFS (HR=6.597 95% CI: 2.882-15.103, P < 0.001) and reduced overall survival (OS) (HR=6.628 95% CI: 2.893-15.183, P < 0.001) of nmCRC patients. In-TLS was not of significance in evaluating the clinical outcomes of nmCRC patients. H-TSP was significantly associated with reduced RFS (HR=0.126 95% CI: 0.048-0.333, P < 0.001) and reduced OS (HR=0.125 95% CI: 0.047-0.332, P < 0.001) of nmCRC patients. The 5-year RFS of the high P-TLS, low-TLS, H-TSP, and L-TSP groups were 89.7%, 47.2%, 53.2%, and 92.5%, respectively. The P-TLS density, TSP and TNM stage were independent prognosis factors of nmCRC patients. The Nomogram, including the P-TLS density, TSP and TNM stage, outperformed the TNM stage.
High P-TLS density and low TSP (L-TSP) were independent and favorable prognostic factors of nmCRC patients, which might provide new directions for targeted therapy in the CRC tumor microenvironment, especially the tumor immune microenvironment.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。